BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 11085922)

  • 1. All natural DR3-type vitamin D response elements show a similar functionality in vitro.
    Toell A; Polly P; Carlberg C
    Biochem J; 2000 Dec; 352 Pt 2(Pt 2):301-9. PubMed ID: 11085922
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ligand-triggered stabilization of vitamin D receptor/retinoid X receptor heterodimer conformations on DR4-type response elements.
    Quack M; Carlberg C
    J Mol Biol; 2000 Feb; 296(3):743-56. PubMed ID: 10677278
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The vitamin D hormone and its nuclear receptor: molecular actions and disease states.
    Haussler MR; Haussler CA; Jurutka PW; Thompson PD; Hsieh JC; Remus LS; Selznick SH; Whitfield GK
    J Endocrinol; 1997 Sep; 154 Suppl():S57-73. PubMed ID: 9379138
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DNA bending is induced by binding of vitamin D receptor-retinoid X receptor heterodimers to vitamin D response elements.
    Kimmel-Jehan C; Darwish HM; Strugnell SA; Jehan F; Wiefling B; DeLuca HF
    J Cell Biochem; 1999 Aug; 74(2):220-8. PubMed ID: 10404392
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vitamin D receptor displays DNA binding and transactivation as a heterodimer with the retinoid X receptor, but not with the thyroid hormone receptor.
    Thompson PD; Hsieh JC; Whitfield GK; Haussler CA; Jurutka PW; Galligan MA; Tillman JB; Spindler SR; Haussler MR
    J Cell Biochem; 1999 Dec; 75(3):462-80. PubMed ID: 10536369
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective recognition of vitamin D receptor conformations mediates promoter selectivity of vitamin D analogs.
    Quack M; Carlberg C
    Mol Pharmacol; 1999 Jun; 55(6):1077-87. PubMed ID: 10347251
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural analysis of RXR-VDR interactions on DR3 DNA.
    Shaffer PL; Gewirth DT
    J Steroid Biochem Mol Biol; 2004 May; 89-90(1-5):215-9. PubMed ID: 15225774
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vitamin D receptor-DNA interactions.
    Shaffer PL; Gewirth DT
    Vitam Horm; 2004; 68():257-73. PubMed ID: 15193458
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vitamin D receptor interactions with the rat parathyroid hormone gene: synergistic effects between two negative vitamin D response elements.
    Russell J; Ashok S; Koszewski NJ
    J Bone Miner Res; 1999 Nov; 14(11):1828-37. PubMed ID: 10571682
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distinct conformations of vitamin D receptor/retinoid X receptor-alpha heterodimers are specified by dinucleotide differences in the vitamin D-responsive elements of the osteocalcin and osteopontin genes.
    Staal A; van Wijnen AJ; Birkenhäger JC; Pols HA; Prahl J; DeLuca H; Gaub MP; Lian JB; Stein GS; van Leeuwen JP; Stein JL
    Mol Endocrinol; 1996 Nov; 10(11):1444-56. PubMed ID: 8923469
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The genes of the coactivator TIF2 and the corepressor SMRT are primary 1alpha,25(OH)2D3 targets.
    Dunlop TW; Väisänen S; Frank C; Carlberg C
    J Steroid Biochem Mol Biol; 2004 May; 89-90(1-5):257-60. PubMed ID: 15225781
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Response element and coactivator-mediated conformational change of the vitamin D(3) receptor permits sensitive interaction with agonists.
    Herdick M; Bury Y; Quack M; Uskokovic MR; Polly P; Carlberg C
    Mol Pharmacol; 2000 Jun; 57(6):1206-17. PubMed ID: 10825392
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New understanding of the molecular mechanism of receptor-mediated genomic actions of the vitamin D hormone.
    Haussler MR; Jurutka PW; Hsieh JC; Thompson PD; Selznick SH; Haussler CA; Whitfield GK
    Bone; 1995 Aug; 17(2 Suppl):33S-38S. PubMed ID: 8579895
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Retinoid X receptor isotype identity directs human vitamin D receptor heterodimer transactivation from the 24-hydroxylase vitamin D response elements in yeast.
    Kephart DD; Walfish PG; DeLuca H; Butt TR
    Mol Endocrinol; 1996 Apr; 10(4):408-19. PubMed ID: 8721985
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Carboxylic ester antagonists of 1alpha,25-dihydroxyvitamin D(3) show cell-specific actions.
    Herdick M; Steinmeyer A; Carlberg C
    Chem Biol; 2000 Nov; 7(11):885-94. PubMed ID: 11094341
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular basis of the selective activity of vitamin D analogues.
    Carlberg C
    J Cell Biochem; 2003 Feb; 88(2):274-81. PubMed ID: 12520526
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Agonist-triggered modulation of the activated and silent state of the vitamin D(3) receptor by interaction with co-repressors and co-activators.
    Herdick M; Carlberg C
    J Mol Biol; 2000 Dec; 304(5):793-801. PubMed ID: 11124027
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of functional vitamin D(3) receptor conformations on DNA-dependent vitamin D(3) signaling.
    Quack M; Carlberg C
    Mol Pharmacol; 2000 Feb; 57(2):375-84. PubMed ID: 10648648
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of the functional vitamin D response elements in the human MDR1 gene.
    Saeki M; Kurose K; Tohkin M; Hasegawa R
    Biochem Pharmacol; 2008 Aug; 76(4):531-42. PubMed ID: 18602086
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vitamin D receptor: key roles in bone mineral pathophysiology, molecular mechanism of action, and novel nutritional ligands.
    Jurutka PW; Bartik L; Whitfield GK; Mathern DR; Barthel TK; Gurevich M; Hsieh JC; Kaczmarska M; Haussler CA; Haussler MR
    J Bone Miner Res; 2007 Dec; 22 Suppl 2():V2-10. PubMed ID: 18290715
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.